Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 54, Issue 4, Pages 353-360
Publisher
Oxford University Press (OUP)
Online
2016-01-07
DOI
10.1093/mmy/myv099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital
- (2015) Evelyn Cabral-Galeano et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
- (2013) Martin Hoenigl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
- (2012) Natalie K. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients
- (2012) S. Pieper et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
- (2012) Alicia Gómez-López et al. MEDICAL MYCOLOGY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study
- (2011) P. Soler-Palacin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical importance of the CYP2C19*17 variant allele for voriconazole
- (2010) Michael J. Dolton et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection
- (2009) Jean-Baptiste Gordien et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now